Publications

BOOK

Vanderpump MPJ & Tunbridge WMG (2008).  "Thyroid Disease: The Facts" 4th edition.  Oxford University Press.

SELECTED ORIGINAL PAPERS

Taylor R, Foster B, Kyne-Grzebalski D & Vanderpump MPJ (1994).  Insulin Regimens for the Non-insulin Dependent: Impact on Diurnal Metabolic State and Quality of Life.  Diabetic Medicine, 11, 6, 551-557. http://grande.nal.usda.gov/ibids/index.php?mode2=detail&origin=ibids_references&therow=63746

Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge FT & Young ET (1995).  The Incidence of Thyroid Disorders in the Community - A Twenty-Year Follow-Up of the Whickham Survey.  Clinical Endocrinology, 43, 55-69.  Abstract published in "1996 Year Book of Medicine", Mosby-Year Book, Inc. http://www3.interscience.wiley.com/journal/119246864/abstract

Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Rodgers H, Tunbridge FT & Young ET (1996).  The Development of Ischemic Heart Disease in Relation to Autoimmune Thyroid Disease in a 20-Year Follow-Up Study of an English Community.  Thyroid, 6, 155-160. http://www.ncbi.nlm.nih.gov/pubmed/8837320

Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Rodgers H, Tunbridge FT & Young ET (1996).  The Incidence of Diabetes Mellitus in an English Community - A Twenty-Year Follow-Up to the Whickham Survey.  Diabetic Medicine, 13, 741-747. http://www3.interscience.wiley.com/journal/109565662/abstract

Vanderpump MPJ, Manning K, Neary RH & Clayton RN (1997).  Does an Increase in the Sensitivity of Serum Thyrotrophin Assays Reduce Diagnostic Costs for Thyroid Disease in the Community?  Journal of the Royal Society of Medicine, 90, 547-550. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=9488012

Vanderpump MPJ, French JM, Appleton D, Tunbridge WMG & Kendall-Taylor P (1998). The Prevalence of Hyperprolactinaemia and Association with Markers of Autoimmune Thyroid Disease in Survivors of the Whickham Survey Cohort.  Clinical Endocrinology, 48, 39-44. http://www3.interscience.wiley.com/journal/119120336/abstract

Vanderpump MPJ, Alexander L, Scarpello JH & Clayton RN (1998).  An Audit of Management of Thyroid Cancer in a Large District General Hospital.  Clinical Endocrinology, 48, 419-424. http://www3.interscience.wiley.com/journal/119120411/abstract

Quinton R, Conway GS, Jacobs HS, Bouloux P-MG & Vanderpump MPJ (1998).  Adult onset idiopathic hypogonadotrophic hypogonadism may be overdiagnosed.  British Medical Journal, 317, 600-601. http://www.bmj.com/cgi/content/extract/317/7158/600

Ramachandran S, French JM, Vanderpump MPJ, Croft P & Neary RH (2000).  Using the Framingham model to predict heart disease in the United Kingdom: retrospective study. British Medical Journal, 320, 676-677. http://www.bmj.com/cgi/content/short/320/7236/676

Ramachandran S, French JM, Vanderpump MPJ, Croft P & Neary RH (2000).  Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction? British Medical Journal, 320, 677-679. http://www.bmj.com/cji/content/short/320/7236/677

Clayton RN, Pfeifer M, Wass JAH, Vanderpump M, Kyridamou E, Simpson D & Farrell WE (2000). Human Pituitary Tumours have Multiclonal Origins.  Clinical Cancer Research, 6, 3973-3982. http://clincancerres.aacrjournals.org/cgi/reprint/6/10/3973

Beaumont NJ, Skinner VO, Tan T M-M, Ramesh BS, Byrne DJ, MacColl GS, Keen JN, Bouloux PM, Mikhailidis DP, Bruckdorfer KR, Vanderpump MP & Srai KS (2003).  Ghrelin can bind to a species of high-density lipoprotein associated with paraxonase.  Journal of Biological Chemistry, 278, 8877-8880. http://www.jbc.org/cgi/reprint/278/11/8877

Martin C, Vanderpump M, French J (2004).  Description and validation of a Markov model of survival for individuals free of cardiovascular disease that uses Framingham risk factors.  BMC Medical Informatics Decision Making, 1472-6947/4/6. http://www.biomedcentral.com/1472-6947/4/6

Tan T M-M, Vanderpump M, Khoo B, Patterson M, Ghatei MA, Goldstone AP (2004).  Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome.  Journal of Clinical Endocrinology and Metabolism, 89, 4162-4165. http://jcem.endojournals.org/cgi/reprint/89/8/4162

Jones G, Vanderpump M, Easton M, Baker D, Ball C, Leenane M, O'Brien H, Turner N, Else M, Reid W & Johnson M (2004).  A strategic approach to achieving compliance with the European Working Time Directive in a large teaching hospital with an acute admissions unit. Clinical Practice, 4, 427-430. http://www.ingentaconnect.com/content/rcop/cm/2004/00000004/00000005/art00012

Patel NN, Abraham P, Buscombe J & Vanderpump MPJ (2006).  The Cost-Effectiveness of Treatment Modalities for Thyrotoxicosis in a UK Centre.  Thyroid, 16, 593-598. http://www.ncbi.nlm/nih.gov/pubmed/16839261?ordinalpos=3&itool=EntrezSystem2.PEntrex.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum

Madge S, Smith CJ, Lampe FC, Thomas M, Johnson MA, Youle M, Vanderpump MPJ (2007). No Association between HIV Disease and its Treatment and Thyroid Function. HIV Medicine, 8, 22-27. http://www3.interscience.wiley.com/journal/118491584/abstract

Razvi S, Shakoor A,Vanderpump M, Weaver J & Pearce S (2008). The influence of age on the relationship between subclinical hypothyroidism and ischaemic heart disease: A meta-analysis. Journal of Clinical Endocrinology and Metabolism , 93 2998-3007.  http://jcem.endojournals.org/cgi/content/abstract/jc.2008-0167v1

SELECTED INVITED REVIEW ARTICLES

Vanderpump MPJ & Tunbridge WMG (1993). The Effects of Drugs on Endocrine Function.  Clinical Endocrinology, 39, 389-397.

Taylor R & Vanderpump MPJ (1994).  New Concepts in Diabetes Mellitus I: treatment, pregnancy and aetiology.  Postgraduate Medical Journal, 70, 824, 418-427. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=8029161

Vanderpump MPJ & Taylor R (1994). New Concepts in Diabetes Mellitus II: complications.  Postgraduate Medical Journal, 70, 825, 479-485. http://www.pubmedcentral.nih.gov/articlerende.fcgi?tool=pubmed&pubmedid=7937425

Tunbridge WMG & Vanderpump MPJ (2000).  Population Screening for Autoimmune Thyroid Disease. Endocrinology and Metabolism Clinics of North America, 29(2), 239-253. http://www.ncbi.nlm.nih.gov/pubmed/10874527?ordinalpos=10&itool=EntrezSystem2.Pentrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum

Vanderpump MPJ & Tunbridge WMG (2002).  Epidemiology and Prevention of Clinical and Subclinical Hypothyroidism.  Thyroid, 12(10), 839-847. http://www.ncbi.nlm.nih.gov/pubmed/12487765?ordinalpos=19&itool-EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum

Vanderpump MPJ (2003).  Subclinical Hypothyroidism - The Case Against Treatment.  Trends in Endocrinology and Metabolism, 14, 262-266.

Hameed S & Vanderpump MPJ (2003).  Common Problems Managing Thyroid Disease in Primary Care. Pulse,63, 26-31.

Vanderpump MPJ & Frankyn JA (2003). Restoring TSH to the reference range should be the goal of replacement. BMJ, 326, 1086-1087.  http://www.bmj.com/cgi/content/extract/326/7398/1086-b

Vanderpump MPJ (2004). Screening for Thyroid Dysfunction. In "Hot Thyoidology" Editorial No 2, July 2004, European Thyroid Association.  http://www.hotthyroidology.com/editorial_130.html

Patel N & Vanderpump MPJ (2005).  Goitres and Thyroid Carcinoma.  Practitioner, 249, 574-577.

Olateju TO & Vanderpump MPJ (2006).  Thyroid Hormone Resistance. Annals of Clinical Biochemistry, 43, 431-440.  Abstract published in Clinical Laboratory (2007) 53:236. http://acb.rsmjournals.com/cgi/content/abstract/43/6/431

Vanderpump MPJ (2007). Invited editorial: Cardiovascular and Cancer Mortality after radioiodine in Hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 92, 2033-2035. http://jcem.endojournals.org/cgi/reprint/92/6/2033

Smellie WSA, Vanderpump MPJ, Fraser WD, Bowlees R & Shaw N (2008). Best practice in primary care pathology: Review 11 Thyroid testing, hypercalcaemia and hypocalcaemia. Journal of Clinical Pathology, 61, 410-418.  http://jcp.bmj.com/cgi/content/abstract/61/4/410?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=vanderpump&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype+HWCIT

Vanderpump MPJ (2008). Is thyroid autoimmunity associated with malignancy?  Nature Clinical Practice Endocrinology and Metabolism, 4, 196-197.

Han TS, Williams GR & Vanderpump MPJ (2009). Benzofuran derivatives and the thyroid. Clinical Endocrinology, 70, 2-13. http://www.ncbi.nlm.nih.gov/pubmed/18727707?log$=activity

SELECTED INVITED CHAPTERS

Vanderpump MPJ & Tunbridge WMG (1996).  The Epidemiology of Thyroid Diseases. In "Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text", 7/E. (Ed. LE Braverman and RD Utiger).  JB Lippincott-Raven, Philadelphia, pp 474-482.

Vanderpump MPJ & Tunbridge WMG (1999). The Epidemiology of Autoimmune Thyroid Disease.  In "The Autoimmune Endocrinopathies", chapter ed. R Volpe for "Volume of Contemporary Endocrinology" (Ed. PM Conn).  Humana Press Inc, New Jersey, pp 141-162.

Vanderpump MPJ & Tunbridge WMG (2000).  The Epidemiology of Thyroid Diseases. In "Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text", 8/E. (Ed.LE Braverman and RD Utiger).   JB Lippincott-Raven, Philadelphia, pp 467-473.

Vanderpump MPJ (2000).  Epidemiology of goiter and hypothyroidism.  In "The Thyroid and Environment". (Ed, F Peter, W Wiersinga, U Hostalek). Schattauer, Stuttgart, pp 3-13.

Vanderpump MPJ & Tunbridge WMG (2002).  Epidemiology of Thyroid Disease and Swelling.  In "The Thyroid", chapter ed. WM Wiersinga for "Oxford Textbook of Endocrinology" (Ed. JAH Wass and SM Shalet).  Oxford University Press, pp 339-349.

Vanderpump MPJ (2004).  Epidemiology of Thyroid Diseases.  In "Encyclopedia of Endocrinology and Endocrine Diseases" (Ed. L Martino and Assc. Ed. W Wiersinga).  Elsevier Academic Press, Oxford, Vol 4, 401-408.

Vanderpump MPJ (2005).  The Epidemiology of Thyroid Diseases. In "Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text", 9/E. (Ed.LE Braverman and RD Utiger).  JB Lippincott-Raven, Philadelphia, pp 398-406.

Vanderpump MPJ (2005).  What to do with Thyroid Nodules and Goitres.  In "Horizons in Medicine 16" (Ed. JA Franklyn).  Royal College of Physicians, London, pp 55-62.

Vanderpump MPJ (2005). Screening for Hypothyroidism: Pros and Cons. In "The Thyroid and Cardiovascular Risk". (Ed, K-M Derwahl, L Duntas and S Butz). Georg Thieme Verlag, Stuttgart, pp 15-23.

Vanderpump MPJ (2008).  Hashimoto's thyroiditis and type 1 diabetes. In "Thyroid Underactivity", chapter ed.  A Weetman for "A Case-Based Textbook of Clinical Endocrinology" (Ed. T DAvis). Humana Press, Totawa, USA pp 93-108.  http://www.springerlink.com/content/p27760442u193652/

Vanderpump MPJ (2009). Thyroid Function and Pregnancy. Epidemiology and Iodine Status. In "The Thyroid and Reproduction". (Ed, J Lazarus, V Pirags and S Butz). Georg Thieme Verlag, Stuttgart, pp 39-45.

Vanderpump MPJ.  Epidemiology of thyroid disease and swelling.  In "The Thyroid", chapter ed. WM Wiersinga for "Oxford Textbook of Endocrinology" (Ed. JAH Wass and P.M. Stewart).  Oxford University Press, in press.

SELECTED OTHER PUBLISHED ABSTRACTS

1. Taylor R, Foster B, Kyne-Grzebalski D & Vanderpump MPJ (1993). Insulin for the non-insulin-dependent: impact on metabolic state and quality of life. British Diabetic Association 1993, Diabetic Medicine Suppl 1 to Vol 10:56.

2. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F & Young ET (1994). The incidence of thyroid disease in the community - a twenty-year follow-up to the Whickham survey. British Endocrine Societies 1994, Journal of Endocrinology Suppl to Vol 140:OC 16.

3. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge FT & Young ET (1994).  The incidence of diabetes mellitus in the community - a twenty-year follow-up to the Whickham survey. British Diabetic Association 1994, Diabetic Medicine Suppl 2 to Vol 11:537.

4. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Clark F, Grimley Evans J & Young ET (1995). A longitudinal study of thyroid disorders in the community. 11th International Thyroid Congress 1995, Thyroid Suppl 1 to Vol 5:S-137.

5. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Clark F, Grimley Evans J & Young ET (1995). No association exists between evidence of thyroid failure and development of ischaemic heart disease in a twenty-year follow-up study of a community. 11th International Thyroid Congress 1995, Thyroid Suppl 1 to Vol 5:S-44.

6. Vanderpump MPJ, Haq N, Harvey TC & Clayton RN (1995).  Severe insulin resistance due to De Morsier's Syndrome. Society for Endocrinology 1995, Journal of Endocrinology Suppl to Vol 147:P-21.

7. Alexander L & Vanderpump MPJ (1996). Recurrent primary hyperparathyroidism 35 years after excision of parathyroid adenoma. British Endocrine Societies 1996, Journal of Endocrinology Suppl to Vol 148:P-346.

10. Vanderpump MPJ, French JM, Appleton D, Kendall-Taylor P & Tunbridge WMG (1996). The prevalence of hyperprolactinaemia and association with markers of autoimmune thyroid disease in survivors of the Whickham survey cohort.  Society for Endocrinology 1996, Journal of Endocrinology, Suppl to Vol 151:P-68.

11. Clayton RN, Pfeifer M, Wass JAH, Vanderpump M, Kyridamou E, Simpson D & Farrell WE (1999). Human pituitary tumours have multiclonal origins. Endocrine Society 1999, Endo '99:OR43-1.

12. Rogers DPS, Bouloux PMG & Vanderpump MPJ (2000). Cytokine-mediated reversible hypopituitarism in POEMS Syndrome. British Endocrine Societies 2000, Journal of Endocrinology Suppl to Volume 164:P-28.

13. Beaumont NJ, Tan TM-M, Skinner VO, Ramesh BS, Byrne DJ, Mikhailidis DP, Bouloux PM, Srai SKS & Vanderpump MP (2002). Ghrelin can bind to a species of HDL. British Endocrine Societies 2002, Journal of Endocrinology 3:OC31 and Endocrine Society 2002, Endo 2002.

14. Tan TMM, Levy M, Skinner V, Beaumont N, Srai K, Goadsby PJ, Bouloux PM & Vanderpump MP (2002). Somatostatin inhibits the release of ghrelin in normal subjects. Society for Endocrinology 2002, Journal of Endocrinology 4:OC4.  Winner of Society for Endocrinology Research Prize.

15. Badman MK, Toh V, Winocour P, Powell M, Vanderpump MP & Katz JR. Medical management of thyrotrophin secreting pituitary adenoma with long acting somatostatin analogue. Society for Endocrinology 2002, Endocrine Abstracts 4:P93.

16. Tan TM-M, Jonas KC, Thurston LM, Vanderpump MP, Hardiman PJ & Michael AE. Ghrelin is a potential paracrine stimulator of 11beta-hydroxysteroid dehydrogenase (11BHSD) in the human ovary. Fertility 2003.

17. Sturrock A, Stearns M, Pigott K, Wiersinga W & Vanderpump M. Recombinant thyrotropin to minimize the risk of deterioration in ophthalmopathy in a patient with papillary thyroid cancer. American Thyroid Association 2003, Thyroid 13:P69.

18. Tan T M-M, Vanderpump M, Khoo B, Patterson M, Ghatei M & Goldstone AP. Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome. Endocrine Society 2004, Endo 2004:OR 27-2.

19. Razvi S, French J, Weaver J, Vanderpump M & Pearce S. The relationship between serum TSH levels and blood pressure in a population sample with normal thyroid function.  British Endocrine Societies 2007, Endocrine Abstracts 13:P341.

20. Razvi S, French J, Weaver J, Vanderpump M & Pearce S. Incident ischaemic heart disease and thyroid status: The Whickham cohort reevaluated. American Thyroid Association 2007, Thyroid 17 Suppl 17:S-72.

21. Martin CJ, Vanderpump M & French J. A new model of cardiovascular disease death, giving individualized risk estimates: An evaluation of the Whickham study. 29th Annual Meeting of the Society for Medical Decision Making, 2007.

22. Vanderpump MPJ, Kyung, Hamda A, Forbes J and Beynon H. Etanercept induced thyroid eye disease. Presented at American Thyroid Association 2009.

23. Rodondi N, den Elzen W; Bauer DC, Cappola AR, Razvi S, Walsh JP, Åsvold BO, Iervasi G, Imaizumi M, Bremner A, Maisonneuve P, Vanderpump M, Newman AB, Cornuz J, Franklyn JA, Westendorp RGJ, Vittinghoff E, Gussekloo J for the Thyroid Studies Collaboration (2010). Subclinical hypothyroidism and the risk of coronary heart disease and mortality: An individual participant data analysis from nine prospective cohort studies. Society for General Internal Medicine, Minneapolis.